Boai NKY Pharmaceuticals Ltd Financial Flexibility Index
Boai NKY Pharmaceuticals Ltd financial flexibility index. Boai NKY Pharmaceuticals Ltd (300109) has a Financial Flexibility Index of 0.33x as of September 2025. Free cash flow of CN¥180.87 Million (operating CF CN¥139.46 Million minus capex CN¥41.41 Million) represents 0% of total liabilities (CN¥552.11 Million). See Boai NKY Pharmaceuticals Ltd (300109) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Boai NKY Pharmaceuticals Ltd (2007–2025)
Financial flexibility index of Boai NKY Pharmaceuticals Ltd from 2007 to 2025. Historical Financial Flexibility Index trend for Boai NKY Pharmaceuticals Ltd across 19 annual periods. Check Boai NKY Pharmaceuticals Ltd (300109) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Boai NKY Pharmaceuticals Ltd Financial Flexibility Index by Year (2007–2025)
Boai NKY Pharmaceuticals Ltd financial flexibility index by year from 2007 to 2025. Year-by-year free cash flow to debt coverage for Boai NKY Pharmaceuticals Ltd. For the full cash flow conversion analysis, see 300109 cash generation efficiency.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.78x | CN¥558.53 Million | CN¥338.11 Million | CN¥713.16 Million | ▲ +12.8% |
| 2024 | 0.69x | CN¥530.72 Million | CN¥256.03 Million | CN¥764.37 Million | ▼ -59.9% |
| 2023 | 1.73x | CN¥866.14 Million | CN¥488.25 Million | CN¥499.66 Million | ▲ +99.6% |
| 2022 | 0.87x | CN¥517.77 Million | CN¥251.77 Million | CN¥596.29 Million | ▲ +88.4% |
| 2021 | 0.46x | CN¥271.76 Million | CN¥43.44 Million | CN¥589.76 Million | ▲ +34.6% |
| 2020 | 0.34x | CN¥366.11 Million | CN¥266.87 Million | CN¥1.07 Billion | ▲ +76.5% |
| 2019 | 0.19x | CN¥221.99 Million | CN¥79.64 Million | CN¥1.14 Billion | ▲ +15.0% |
| 2018 | 0.17x | CN¥173.18 Million | CN¥48.81 Million | CN¥1.03 Billion | ▼ -37.3% |
| 2017 | 0.27x | CN¥176.51 Million | CN¥47.28 Million | CN¥656.22 Million | ▼ -86.2% |
| 2016 | 1.95x | CN¥162.61 Million | CN¥114.14 Million | CN¥83.32 Million | ▲ +36.4% |
| 2015 | 1.43x | CN¥104.59 Million | CN¥64.12 Million | CN¥73.11 Million | ▲ +13.6% |
| 2014 | 1.26x | CN¥93.71 Million | CN¥46.60 Million | CN¥74.38 Million | ▼ -2.1% |
| 2013 | 1.29x | CN¥58.65 Million | CN¥23.17 Million | CN¥45.58 Million | ▼ -47.2% |
| 2012 | 2.44x | CN¥111.61 Million | CN¥20.65 Million | CN¥45.81 Million | ▼ -12.7% |
| 2011 | 2.79x | CN¥108.24 Million | CN¥3.94 Million | CN¥38.80 Million | ▲ +118.3% |
| 2010 | 1.28x | CN¥31.43 Million | CN¥10.05 Million | CN¥24.60 Million | ▲ +15.5% |
| 2009 | 1.11x | CN¥53.84 Million | CN¥28.57 Million | CN¥48.66 Million | ▲ +864.4% |
| 2008 | 0.11x | CN¥5.45 Million | CN¥-4.09 Million | CN¥47.52 Million | ▼ -60.9% |
| 2007 | 0.29x | CN¥14.33 Million | CN¥9.56 Million | CN¥48.84 Million | — |